Purchases and Sales Made in Q2 2025 in Moon Lake Immunotherapeutics (MLTX)
This table provides information about the institutional ownership of Moon Lake Immunotherapeutics (MLTX) during Q2 2025. The information is specifically focused on institutions that hold shares of MoonLake Immunotherapeutics.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2025
Q2 2025
|
Octagon Capital Advisors LP
New York, NY |
SELL
|
- |
-148K- 50.0% |
$4.86M - $7.56M
|
148K
$7.88M
|
|
|
Aug 14, 2025
Q2 2025
|
Logos Global Management LP
San Francisco, CA |
SELL
|
- |
-150K- 42.86% |
$4.93M - $7.66M
|
200K
$10.7M
|
|
|
Aug 13, 2025
Q2 2025
|
Pictet Asset Management Holding Sa
Carouge, V8 |
SELL
|
- |
-174K- 54.14% |
$5.73M - $8.9M
|
148K
$7.87M
|
|
|
Aug 14, 2025
Q2 2025
|
Fred Alger Management, LLC
New York, NY |
SELL
|
- |
-347K- 54.02% |
$11.4M - $17.7M
|
296K
$15.7M
|
|
|
Aug 14, 2025
Q2 2025
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-361K- 12.13% |
$11.8M - $18.4M
|
2.61M
$139M
|
|
|
Aug 14, 2025
Q2 2025
|
Polar Capital Holdings PLC
London, X0 |
SELL
|
- |
-853K- 77.5% |
$28M - $43.5M
|
248K
$13.2M
|